
pmid: 17350500
Cutaneous leishmaniasis is a widespread tropical infection caused by numerous different species of Leishmania protozoa that are transmitted by sandflies. Its clinical presentations are extremely diverse and dependent on a variety of parasite and host factors that are poorly understood. Diagnosis should aim to identify the exact species involved, but this requires laboratory investigations that are not widely available. No single ideal treatment has been identified, and those available are limited by variable success rates and toxicity. Clinical guidelines are needed to make better use of the investigations and treatments that do exist. Prevention is currently limited to bite prevention measures.
Antifungal Agents, Paromomycin, Antiprotozoal Agents, Leishmaniasis, Cutaneous, Hyperthermia, Induced, Curettage, Diagnosis, Differential, Antimony Sodium Gluconate, Cryotherapy, Benzethonium, Humans, Amebicides
Antifungal Agents, Paromomycin, Antiprotozoal Agents, Leishmaniasis, Cutaneous, Hyperthermia, Induced, Curettage, Diagnosis, Differential, Antimony Sodium Gluconate, Cryotherapy, Benzethonium, Humans, Amebicides
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 224 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Top 1% | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Top 1% | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Top 1% |
